IL149779A0 - A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias - Google Patents

A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Info

Publication number: IL149779A0
Authority: IL; Israel
Prior art keywords: prostate; vaccine; hyperplasias; lactobacilli; inflammation
Prior art date: 1999-11-25

Application number

IL14977900A

Other languages

English (en)

Original Assignee

Vakcina Kft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-25

Filing date

2000-11-23

Publication date

2002-11-10

2000-11-23 Application filed by Vakcina Kft filed Critical Vakcina Kft

2002-11-10 Publication of IL149779A0 publication Critical patent/IL149779A0/xx

Links

229960005486 vaccine Drugs 0.000 title abstract 3
206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract 2
206010061218 Inflammation Diseases 0.000 title abstract 2
241000186660 Lactobacillus Species 0.000 title abstract 2
230000004054 inflammatory process Effects 0.000 title abstract 2
210000002307 prostate Anatomy 0.000 title abstract 2
239000000969 carrier Substances 0.000 abstract 1
229940039696 lactobacillus Drugs 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL14977900A 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias IL149779A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU9904408A HU227086B1 (en)	1999-11-25	1999-11-25	Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
PCT/HU2000/000122 WO2001037862A2 (en)	1999-11-25	2000-11-23	A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Publications (1)

Publication Number	Publication Date
IL149779A0 true IL149779A0 (en)	2002-11-10

Family

ID=90014600

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14977900A IL149779A0 (en)	1999-11-25	2000-11-23	A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
IL149779A IL149779A (en)	1999-11-25	2002-05-21	Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias and its production

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL149779A IL149779A (en)	1999-11-25	2002-05-21	Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias and its production

Country Status (20)

Country	Link
US (4)	US20080175865A1 (cs)
EP (1)	EP1272216B1 (cs)
AT (1)	ATE470452T1 (cs)
AU (1)	AU779214B2 (cs)
CA (1)	CA2394843C (cs)
CZ (1)	CZ302662B6 (cs)
DE (1)	DE60044539D1 (cs)
DK (1)	DK1272216T3 (cs)
EA (1)	EA005198B1 (cs)
ES (1)	ES2348591T3 (cs)
HU (1)	HU227086B1 (cs)
IL (2)	IL149779A0 (cs)
PL (1)	PL201804B1 (cs)
PT (1)	PT1272216E (cs)
RO (1)	RO122760B1 (cs)
RS (1)	RS51201B (cs)
SI (1)	SI20960B (cs)
SK (1)	SK288132B6 (cs)
UA (1)	UA78673C2 (cs)
WO (1)	WO2001037862A2 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1723965A1 (en)	2005-05-18	2006-11-22	Stallergenes Sa	Compositions for antigen-specific induction of immuno-tolerance via oral immunization
US9732131B2 (en)	2006-02-27	2017-08-15	Calviri, Inc.	Identification and use of novopeptides for the treatment of cancer
US20110027348A1 (en)	2007-08-27	2011-02-03	Janos Feher	Composition and method inhibiting inflammation
EP3630131B1 (en)	2017-06-02	2022-08-31	Arizona Board of Regents on behalf of Arizona State University	A method to create personalized canine cancer vaccines
US12025615B2 (en)	2017-09-15	2024-07-02	Arizona Board Of Regents On Behalf Of Arizona State University	Methods of classifying response to immunotherapy for cancer
ES2987106T3 (es) *	2017-12-19	2024-11-13	Int N&H Denmark Aps	Probióticos para la salud cognitiva y mental
EP4038222A4 (en)	2019-10-02	2023-10-18	Arizona Board of Regents on behalf of Arizona State University	Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH639280A5 (de) *	1977-12-23	1983-11-15	Solco Basel Ag	Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
DE19522472C2 (de) *	1995-06-21	1998-07-02	Eugen Baumgaertner	Herstellungsverfahren eines Fermentationsproduktes zur Behandlung von Prostataleiden
EP1007625B1 (en) *	1997-08-21	2010-08-11	New Zealand Dairy Board	Immunity enhancing lactic acid bacteria
IT1298918B1 (it) *	1998-02-20	2000-02-07	Mendes Srl	Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1306716B1 (it) *	1999-06-21	2001-10-02	Mendes S U R L	Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

1999
- 1999-11-25 HU HU9904408A patent/HU227086B1/hu unknown
2000
- 2000-11-23 DE DE60044539T patent/DE60044539D1/de not_active Expired - Lifetime
- 2000-11-23 EA EA200200602A patent/EA005198B1/ru not_active IP Right Cessation
- 2000-11-23 RS YUP-374/02A patent/RS51201B/sr unknown
- 2000-11-23 CA CA2394843A patent/CA2394843C/en not_active Expired - Fee Related
- 2000-11-23 PT PT00981507T patent/PT1272216E/pt unknown
- 2000-11-23 SI SI200020063A patent/SI20960B/sl active Search and Examination
- 2000-11-23 ES ES00981507T patent/ES2348591T3/es not_active Expired - Lifetime
- 2000-11-23 WO PCT/HU2000/000122 patent/WO2001037862A2/en not_active Ceased
- 2000-11-23 EP EP00981507A patent/EP1272216B1/en not_active Expired - Lifetime
- 2000-11-23 PL PL355886A patent/PL201804B1/pl unknown
- 2000-11-23 IL IL14977900A patent/IL149779A0/xx unknown
- 2000-11-23 DK DK00981507.7T patent/DK1272216T3/da active
- 2000-11-23 AT AT00981507T patent/ATE470452T1/de active
- 2000-11-23 UA UA2002064624A patent/UA78673C2/uk unknown
- 2000-11-23 SK SK738-2002A patent/SK288132B6/sk not_active IP Right Cessation
- 2000-11-23 CZ CZ20021771A patent/CZ302662B6/cs not_active IP Right Cessation
- 2000-11-23 RO ROA200200663A patent/RO122760B1/ro unknown
- 2000-11-23 AU AU18741/01A patent/AU779214B2/en not_active Ceased
2002
- 2002-05-21 IL IL149779A patent/IL149779A/en not_active IP Right Cessation
2008
- 2008-03-21 US US12/077,780 patent/US20080175865A1/en not_active Abandoned
2011
- 2011-03-16 US US13/049,344 patent/US9056073B2/en not_active Expired - Fee Related
2015
- 2015-06-10 US US14/735,637 patent/US20160051657A1/en not_active Abandoned
2018
- 2018-02-08 US US15/891,620 patent/US20180161414A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20180161414A1 (en)	2018-06-14
CZ20021771A3 (cs)	2002-11-13
US20160051657A1 (en)	2016-02-25
AU779214B2 (en)	2005-01-13
HUP9904408D0 (en)	2000-01-28
WO2001037862A3 (en)	2001-11-22
YU37402A (sh)	2005-06-10
US20110243990A1 (en)	2011-10-06
CZ302662B6 (cs)	2011-08-24
WO2001037862A2 (en)	2001-05-31
SI20960B (sl)	2011-01-31
ATE470452T1 (de)	2010-06-15
HUP9904408A2 (hu)	2002-03-28
EP1272216A2 (en)	2003-01-08
US20080175865A1 (en)	2008-07-24
PL201804B1 (pl)	2009-05-29
SK7382002A3 (en)	2002-11-06
SK288132B6 (sk)	2013-10-02
DE60044539D1 (de)	2010-07-22
US9056073B2 (en)	2015-06-16
CA2394843C (en)	2011-01-18
ES2348591T3 (es)	2010-12-09
SI20960A (sl)	2003-02-28
DK1272216T3 (da)	2010-09-27
AU1874101A (en)	2001-06-04
RO122760B1 (ro)	2010-01-29
RS51201B (sr)	2010-12-31
EP1272216B1 (en)	2010-06-09
EA005198B1 (ru)	2004-12-30
PT1272216E (pt)	2010-09-14
IL149779A (en)	2009-05-04
EA200200602A1 (ru)	2002-10-31
UA78673C2 (en)	2007-04-25
CA2394843A1 (en)	2001-05-31
HU227086B1 (en)	2010-06-28
PL355886A1 (en)	2004-05-31

Publication	Publication Date	Title
MY125387A (en)	2006-07-31	Vaccine
BG101995A (en)	1998-11-30	Saponin and sterol-containing vaccines
MY119276A (en)	2005-04-30	Pharmaceutical composition for immunomodulation based on peptides and adjuvants
IS5329A (is)	1999-12-29	Flutningskerfi fyrir antígen þar sem monoglýseríðeða díglýseríð afleiður eru ónæmisglæðar
AU5821000A (en)	2001-01-31	Vaccine
AU2535997A (en)	1997-10-10	Prostate specific antigen oligo-epitope peptide
AP2002002445A0 (en)	2002-03-31	Oral recombinant lactobacilli vaccines.
NZ287385A (en)	1998-10-28	Antigenic preparation comprising the catalase of helicobacter bacteria and vaccines used to treat helicobacter infection
IL154913A0 (en)	2003-10-31	Composition comprising immunogenic microparticles
AU2001294834A1 (en)	2002-04-08	Recombinant bcg vaccines for the prevention and treatment of cancer
ATE270707T1 (de)	2004-07-15	Entepneumovirus und entsprechendes impfstoff
SE9600647D0 (sv)	1996-02-21	Ny användning
AU8113591A (en)	1992-01-23	Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
PL355886A1 (en)	2004-05-31	A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
AU2002217043A1 (en)	2002-05-27	Salmonella vaccine
AU1074902A (en)	2002-05-15	Kahalalide f
MXPA02010173A (es)	2003-06-04	Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis.
WO2002076485A3 (en)	2003-05-30	Vaccine for modulating between t1 and t2 immune responses
WO1997047271A3 (en)	1998-02-12	Cellular vaccines and immunotherapeutics and methods for their preparation
AU4630700A (en)	2000-12-05	Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
WO2000012122A3 (de)	2000-06-22	Niedermolekulare fragmente der hyaluronsäure zur herstellung von impfstoffen
AU1201801A (en)	2001-08-07	Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
NZ512850A (en)	2004-01-30	Treatment of papillomavirus infections
AU3991899A (en)	1999-12-06	Verotoxin b subunit for immunization
WO2002038739A3 (en)	2002-10-24	Bacterial expression systems